ID   MRP3_RAT                Reviewed;        1522 AA.
AC   O88563; O88270;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=ATP-binding cassette sub-family C member 3;
DE            EC=7.6.2.- {ECO:0000269|PubMed:10644759};
DE            EC=7.6.2.2 {ECO:0000250|UniProtKB:O15438};
DE            EC=7.6.2.3 {ECO:0000250|UniProtKB:O15438};
DE   AltName: Full=Canalicular multispecific organic anion transporter 2;
DE   AltName: Full=MRP-like protein 2 {ECO:0000303|PubMed:9614210};
DE            Short=MLP-2 {ECO:0000303|PubMed:9614210};
DE   AltName: Full=Multidrug resistance-associated protein 3;
GN   Name=Abcc3; Synonyms=Cmoat2, Mlp2, Mrp3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Colon;
RX   PubMed=9614210;
RA   Hirohashi T., Suzuki H., Ito K., Ogawa K., Kume K., Shimizu T.,
RA   Sugiyama Y.;
RT   "Hepatic expression of multidrug resistance-associated protein-like
RT   proteins maintained in eisai hyperbilirubinemic rats.";
RL   Mol. Pharmacol. 53:1068-1075(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=10362653; DOI=10.1152/ajpgi.1999.276.6.g1493;
RA   Ortiz D.F., Li S., Iyer R., Zhang X., Novikoff P., Arias I.M.;
RT   "MRP3, a new ATP-binding cassette protein localized to the canalicular
RT   domain of the hepatocyte.";
RL   Am. J. Physiol. 276:G1493-G1500(1999).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10644759; DOI=10.1074/jbc.275.4.2905;
RA   Hirohashi T., Suzuki H., Takikawa H., Sugiyama Y.;
RT   "ATP-dependent transport of bile salts by rat multidrug resistance-
RT   associated protein 3 (Mrp3).";
RL   J. Biol. Chem. 275:2905-2910(2000).
RN   [4]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11897632; DOI=10.1152/ajpgi.00318.2001;
RA   Rost D., Mahner S., Sugiyama Y., Stremmel W.;
RT   "Expression and localization of the multidrug resistance-associated protein
RT   3 in rat small and large intestine.";
RL   Am. J. Physiol. 282:G720-G726(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-902 AND SER-905, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC)
CC       family that binds and hydrolyzes ATP to enable active transport of
CC       various substrates including many drugs, toxicants and endogenous
CC       compound across cell membranes. Transports glucuronide conjugates such
CC       as bilirubin diglucuronide, estradiol-17-beta-o-glucuronide and GSH
CC       conjugates such as leukotriene C4 (LTC4) (By similarity). Transports
CC       also various bile salts (taurocholate, glycocholate,
CC       taurochenodeoxycholate-3-sulfate, taurolithocholate- 3-sulfate). Does
CC       not contribute substantially to bile salt physiology but provides an
CC       alternative route for the export of bile acids and glucuronides from
CC       cholestatic hepatocytes (By similarity). May contribute to regulate the
CC       transport of organic compounds in testes across the blood-testis-
CC       barrier (By similarity). {ECO:0000250|UniProtKB:B2RX12,
CC       ECO:0000250|UniProtKB:O15438}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione(in) + ATP + H2O = ADP + an S-
CC         substituted glutathione(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:456216; EC=7.6.2.3;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + taurocholate(in) = ADP + H(+) + phosphate +
CC         taurocholate(out); Xref=Rhea:RHEA:50052, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:36257,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10644759};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50053;
CC         Evidence={ECO:0000305|PubMed:10644759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glycocholate(in) + H2O = ADP + glycocholate(out) + H(+)
CC         + phosphate; Xref=Rhea:RHEA:50056, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29746, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10644759};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50057;
CC         Evidence={ECO:0000305|PubMed:10644759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + taurolithocholate 3-sulfate(in) = ADP + H(+) +
CC         phosphate + taurolithocholate 3-sulfate(out); Xref=Rhea:RHEA:50084,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58301, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10644759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O =
CC         17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:60128, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:82961, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10644759};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60129;
CC         Evidence={ECO:0000305|PubMed:10644759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + dehydroepiandrosterone 3-sulfate(in) + H2O = ADP +
CC         dehydroepiandrosterone 3-sulfate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:61364, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57905,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:O15438};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61365;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene C4(in) = ADP + H(+) + leukotriene
CC         C4(out) + phosphate; Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside(in) + ATP +
CC         H2O = (4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside(out) + ADP +
CC         H(+) + phosphate; Xref=Rhea:RHEA:66180, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:229704, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66181;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-bisglucuronoside(in)
CC         + ATP + H2O = (4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-
CC         bisglucuronoside(out) + ADP + H(+) + phosphate; Xref=Rhea:RHEA:66192,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:229706, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66193;
CC         Evidence={ECO:0000250|UniProtKB:O15438};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + taurochenodeoxycholate 3-sulfate(in) = ADP + H(+)
CC         + phosphate + taurochenodeoxycholate 3-sulfate(out);
CC         Xref=Rhea:RHEA:66176, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:166912,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:10644759};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66177;
CC         Evidence={ECO:0000305|PubMed:10644759};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.36 uM for ATP (determined by measuring estradiol-17-beta-o-
CC         glucuronide transport) {ECO:0000269|PubMed:10644759};
CC         KM=3.06 uM for taurolithocholate sulfate
CC         {ECO:0000269|PubMed:10644759};
CC         KM=15.9 uM for taurocholate {ECO:0000269|PubMed:10644759};
CC         Vmax=161.9 pmol/min/mg enzyme for taurolithocholate-3-sulfate
CC         {ECO:0000269|PubMed:10644759};
CC         Vmax=50.1 pmol/min/mg enzyme for taurocholate transport
CC         {ECO:0000269|PubMed:10644759};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:11897632}; Multi-pass membrane protein
CC       {ECO:0000255}. Basal cell membrane {ECO:0000250|UniProtKB:O15438};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in lung, ileum, colon and liver. Higher
CC       in liver of Eisai hyperbilirubinemic rats.
CC       {ECO:0000269|PubMed:9614210}.
CC   -!- INDUCTION: Strongly up-regulated under conditions of cholestasis.
CC       {ECO:0000269|PubMed:9614210}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC family.
CC       Conjugate transporter (TC 3.A.1.208) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA28955.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF072816; AAC25416.1; -; mRNA.
DR   EMBL; AB010467; BAA28955.1; ALT_FRAME; mRNA.
DR   RefSeq; NP_542148.1; NM_080581.1.
DR   AlphaFoldDB; O88563; -.
DR   SMR; O88563; -.
DR   BioGRID; 250828; 1.
DR   STRING; 10116.ENSRNOP00000003977; -.
DR   BindingDB; O88563; -.
DR   ChEMBL; CHEMBL2073682; -.
DR   GlyCosmos; O88563; 3 sites, No reported glycans.
DR   GlyGen; O88563; 3 sites.
DR   iPTMnet; O88563; -.
DR   PhosphoSitePlus; O88563; -.
DR   PaxDb; 10116-ENSRNOP00000003977; -.
DR   GeneID; 140668; -.
DR   KEGG; rno:140668; -.
DR   AGR; RGD:71101; -.
DR   CTD; 8714; -.
DR   RGD; 71101; Abcc3.
DR   eggNOG; KOG0054; Eukaryota.
DR   InParanoid; O88563; -.
DR   OrthoDB; 3384185at2759; -.
DR   PhylomeDB; O88563; -.
DR   Reactome; R-RNO-159418; Recycling of bile acids and salts.
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   PRO; PR:O88563; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0015432; F:ABC-type bile acid transporter activity; IDA:UniProtKB.
DR   GO; GO:0015431; F:ABC-type glutathione S-conjugate transporter activity; ISS:UniProtKB.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0015164; F:glucuronoside transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0071714; F:icosanoid transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015721; P:bile acid and bile salt transport; IMP:UniProtKB.
DR   GO; GO:0015722; P:canalicular bile acid transport; IDA:MGI.
DR   GO; GO:0071716; P:leukotriene transport; ISS:UniProtKB.
DR   GO; GO:0098656; P:monoatomic anion transmembrane transport; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IMP:RGD.
DR   GO; GO:0006855; P:xenobiotic transmembrane transport; ISO:RGD.
DR   GO; GO:0042908; P:xenobiotic transport; ISO:RGD.
DR   CDD; cd18595; ABC_6TM_MRP1_2_3_6_D1_like; 1.
DR   CDD; cd18603; ABC_6TM_MRP1_2_3_6_D2_like; 1.
DR   CDD; cd03250; ABCC_MRP_domain1; 1.
DR   CDD; cd03244; ABCC_MRP_domain2; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR050173; ABC_transporter_C.
DR   InterPro; IPR005292; MRP.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR00957; MRP_assoc_pro; 1.
DR   PANTHER; PTHR24223; ATP-BINDING CASSETTE SUB-FAMILY C; 1.
DR   PANTHER; PTHR24223:SF405; ATP-BINDING CASSETTE SUB-FAMILY C MEMBER 3; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Glycoprotein; Lipid transport; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Translocase; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1522
FT                   /note="ATP-binding cassette sub-family C member 3"
FT                   /id="PRO_0000093361"
FT   TOPO_DOM        1..32
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        33..53
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        54..73
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        74..94
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        95..99
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        100..120
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        121..132
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        133..153
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        154..171
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        172..192
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        193..301
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        302..322
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        323..347
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        348..368
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        369..424
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        425..445
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        446..448
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        449..469
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        470..531
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        532..552
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        553..574
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        575..595
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        596..958
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        959..979
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        980..1016
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1017..1037
FT                   /note="Helical; Name=13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1038..1080
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1081..1101
FT                   /note="Helical; Name=14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1102
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1103..1123
FT                   /note="Helical; Name=15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1124..1194
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1195..1215
FT                   /note="Helical; Name=16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1216..1217
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1218..1238
FT                   /note="Helical; Name=17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1239..1522
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   DOMAIN          310..592
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          625..849
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          966..1247
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1286..1518
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         659..666
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         1318..1325
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   MOD_RES         902
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         905
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        18
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1001
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1002
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        645
FT                   /note="I -> L (in Ref. 1; BAA28955)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1075
FT                   /note="H -> D (in Ref. 1; BAA28955)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1522 AA;  168978 MW;  740E31E0C4C64297 CRC64;
     MDRLCGSGEL GSKFWDSNLT VYTNTPDLTP CFQNSLLAWV PCIYLWAALP CYLFYLRHHR
     LGYIVLSCLS RLKTALGVLL WCISWVDLFY SFHGLVHGSS PAPVFFITPL LVGITMLLAT
     LLIQYERLRG VRSSGVLIIF WLLCVICAII PFRSKILLAL AEGKILDPFR FTTFYIYFAL
     VLCAFILSCF QEKPPLFSPE NLDTNPCPEA SAGFFSRLSF WWFTKLAILG YRRPLEDSDL
     WSLSEEDCSH KVVQRLLEAW QKQQTQASGP QTAALEPKIA GEDEVLLKAR PKTKKPSFLR
     ALVRTFTSSL LMGACFKLIQ DLSPSSTHSC SASSSGLFRP HGPYWWGFLL AGLMFVSSTM
     QTLILHQHYH CIFVMALRIR TAIIGVIYRK ALTITNSVKR EYTVGEMVNL MSVDAQRFMD
     VSPFINLLWS APLQVILAIY FLWQILGPSA LAGVAVIVLL IPLNGAVSMK MKTYQVQQMK
     FKDSRIKLMS EILNGIKVLK LYAWEPTFLE QVEGIRQGEL QLLRKGAYLQ AISTFIWVCT
     PFMVTLITLG VYVCVDKNNV LDAEKAFVSL SLFNILKIPL NLLPQLISGM TQTSVSLKRI
     QDFLNQDELD PQCVERKTIS PGRAITIHNG TFSWSKDLPP TLHSINIQIP KGALVAVVGP
     VGCGKSSLVS ALLGEMEKLE GAVSVKGSVA YVPQQAWIQN CTLQENVLFG QPMNPKRYQQ
     ALETCALLAD LDVLPGGDQT EIGEKGINLS GGQRQRVSLA RAVYSDANIF LLDDPLSAVD
     SHVAKHIFDQ VIGPEGVLAG KTRVLVTHGI SFLPQTDFII VLADGQITEM GHYSELLQHD
     GSFANFLRNY APDENQEANE GVLQHANEEV LLLEDTLSTH TDLTDTEPAI YEVRKQFMRE
     MSSLSSEGEG QNRPVLKRYT SSLEKEVPAT QTKETGALIK EEIAETGNVK LSVYWDYAKS
     VGLCTTLFIC LLYAGQNAVA IGANVWLSAW TNDVEEHGQQ NNTSVRLGVY ATLGILQGLL
     VMLSAFTMVV GAIQAARLLH TALLHNQIRA PQSFFDTTPS GRILNRFSKD IYVIHEVLAP
     TILMLFNSFY TSISTIVVIV ASTPLFCVVV LPLAVFYGFV QRFYVATSRQ LKRLESVSRS
     PIFSHFSETV TGTSVIRAYG RVQDFKVLSD AKVDSNQKTT YPYIASNRWL GVHVEFVGNC
     VVLFSALFAV IGRNSLNPGL VGLSVSYALQ VTLSLNWMIR TLSDLESNII AVERVKEYSK
     TETEAPWVLE SNRAPEGWPR SGVVEFRNYS VRYRPGLELV LKNLTLHVQG GEKVGIVGRT
     GAGKSSMTLC LFRILEAAEG EIFIDGLNVA HIGLHDLRSQ LTIIPQDPIL FSGTLRMNLD
     PFGRYSDEDI WRTLELSHLS AFVSSQPTGL DFQCSEGGDN LSVGQRQLVC LARALLRKSR
     VLVLDEATAA IDLETDDLIQ GTIRTQFEDC TVLTIAHRLN TIMDYNRVLV LDKGVVAEFD
     SPVNLIAAGG IFYGMAKDAG LA
//
